SEC Form 4 · accession 0001179110-16-028968
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Junning Lee
Officer — Sr. VP, Technical Operations
Period of report
Aug 20, 2016
Accepted (ET)
Aug 23, 2016 · 7:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 20, 2016 | F | 3,785 | $27.89 | D | 238,467 | D | |
| Ordinary SharesF1 | holding | — | — | — | 9,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By Spouse as holder of self directed retirement account. Reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein.